Fundraising Fox
Seremedi
Techstars '17Houston, US · Founded 2014 · Delaware corporation · 5 employees on LinkedIn · 1 known investors
Find your way into Seremedi
Sign up to see every warm intro you have to Seremedi
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Seremedi team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Seremedi provides a digital app that guides post-procedure care for aesthetic procedures, offering personalized care plans for clients and documentation tools for nurses and care providers.
Also known as CX-Aesthetic · Seremedi Aesthetics · Seremedi, Inc.
Founders & leadership
Seremedi was founded in 2014 by Kim Bond Evans.
Board
Investors · 1
How we know: the Techstars portfolio · open dataset · Top 3000 Accelerator Startups (no YC) 2026-08 · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$200K disclosed across 1 round · 2016
▶$200KraisedJan 2017 · 1 investors · Other Health CareRule 506(b)
- David MiddletonExecutive Officer
- Cody MenardExecutive Officer, Director, Promoter
- Andre PontinExecutive Officer
- Kim Bond EvansExecutive Officer, Director, Promoter
- Nicholas RockecharlieExecutive Officer, Director
- Felicity McGourtyExecutive Officer
- Alex BentonDirector
- Melanie AchardExecutive Officer
- Offering amount
- $3M
- Amount sold
- $200K
- Minimum investment
- $100K
- Proceeds to insiders
- $1M
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b, 4a5
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Company profile
researched Sep 2026Seremedi, Inc. is a Houston, Texas digital health company founded in 2014 that builds cloud-based software for guided patient recovery. Its current product, the Seremedi Aesthetics app (marketed under the CX-Aesthetic banner), gives aesthetic-procedure nurses and care providers a digitally prescribed care plan for clients, covering vitals monitoring, medication management, symptom tracking, timely care-task reminders, follow-up appointment reminders and documented, procedure-specific care tasks. The company positions the tool around the period immediately after discharge, when recovery care has traditionally been handled by untrained friends or family members, and produces a documented record of services delivered.
Earlier, the company marketed CareScriptions, a mobile care-coordination platform for perioperative care, and a broader connected-health platform intended to let clinical teams, patients and family caregivers manage complex care needs at home. That platform offered real-time monitoring and reporting of vital signs, symptoms and treatment non-adherence, plus uploaded images and online consultations intended to detect preventable complications early and reduce readmission costs, risks and penalties. Seremedi describes its team as clinicians, patients, caregivers and security management experts.
Business model
Seremedi sells its app to aesthetic clinics and care providers, who use it with their clients; the site directs prospects to a sales contact and demo scheduling, and also lists partnership opportunities and a clinical-trial client-engagement service line.
Traction
Third-party directories place the company at roughly 1-10 employees and estimate annual revenue below $1 million. Public recognition includes selection of the CareScriptions patient care platform as a 2016 finalist in the MEDICA World App Competition.
Latest developments
The company currently markets the Seremedi Aesthetics app for post-aesthetic-procedure care and lists a clinical-trial client-engagement service among its offerings.
▸Full profile — market position, technology, go-to-market, geography, history
Market position
A small company with fewer than ten employees operating in the hospitals and health care sector, positioned in care coordination and remote patient monitoring alongside larger practice-management and care-platform vendors.
Seremedi frames its offering as a tailored, digitally prescribed care plan for the post-procedure recovery window, replacing generic one-size-fits-all home care and untrained family caregiving, with a documented record of services rendered.
Technology
Cloud-based, browser-delivered application requiring no software installation, supported on desktop and laptop browsers including Google Chrome, Firefox, Safari and Microsoft Edge. The company states HIPAA and GDPR compliance and encrypted data transmission and storage over 2048-bit SSL connections. Functional components include vitals monitoring, medication management, symptom tracking, image upload, online consultation and documented care-task workflows.
Go-to-market
Direct sales through website demo requests and sales/info email contacts, supported by referenceable customers such as Blushing Dolls in Miami, Florida; earlier visibility came from industry events such as the Annual Perioperative Surgical Home Summit and the MEDICA World App Competition, and from residency at JLABS @ TMC.
Aesthetic procedure nurses, care providers and clinics, and their post-procedure clients; historically also hospital and health-system clinical teams managing perioperative and home-based post-acute care.
Geography
Headquartered at 2450 Holcombe Boulevard, Suite J, Houston, Texas, United States, with employees in North America; customers cited include a provider in Miami, Florida.
History
Seremedi, Inc. was founded in 2014 and is headquartered in Houston, Texas. In 2016 it launched its CareScriptions PDQ program at the Annual Perioperative Surgical Home Summit in Chicago and was named a finalist in the MEDICA World App Competition while a resident company of JLABS @ TMC. The company later focused its offering on aesthetic-procedure recovery with the Seremedi Aesthetics app.
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 2
launches, deals, and filingsSeremedi's CareScriptions patient care platform was selected as a finalist for the 2016 MEDICA World App Competition; the company was then a resident company of JLABS @ TMC.
Seremedi announced the launch of its CareScriptions PDQ program at the Annual Perioperative Surgical Home Summit in Chicago.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
Legal entities · 1
corporate structure▸Research sources · 8
primary sources listed
- Seremediseremedi.com · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Seremedi do?
- Houston-based digital health company whose app guides nurses and care providers through post-aesthetic-procedure recovery care.
- Who founded Seremedi?
- Seremedi was founded by Kim Bond Evans in 2014.
- Who are Seremedi's investors?
- Seremedi's investors include Techstars.
- How much funding has Seremedi raised?
- Seremedi has disclosed $200K raised across 1 round.
- Where is Seremedi headquartered?
- Seremedi is headquartered in Houston, US.